SOLIQUA Instructions for use

This product is a combination of insulin glargine and lixisenatide. This product is indicated for the treatment of adults with type 2 diabetes mellitus with inadequate glycemic control, in combination with other oral antihyperglycemic agents, on a background of diet and exercise to improve glycemic control.


File format
PDF
Published
30 October, 2023
Updated
30 October, 2023
MD5 checksum
627D1FCA039873D09F2E35981FE60277
Download PDF

Also Manuals